Sacituzumab govitecan trials for Metastatic Breast Cancer

All Sacituzumab govitecan trials · All Metastatic Breast Cancer trials

Phase breakdown

Recruiting trials studying Sacituzumab govitecan for Metastatic Breast Cancer

• A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
  NCT03424005 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 53 locations
• Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
  NCT07582887 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Scalp Cooling in MBC
  NCT04986579 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
  NCT06263543 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
  NCT06409390 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials study Sacituzumab govitecan for Metastatic Breast Cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.